- Home
- SAP vs MRK Comparison
SAP vs MRK Comparison
Compare SAP & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAP
- MRK
- Stock Information
- Founded
- SAP 1972
- MRK 2000
- Country
- SAP Germany
- MRK United States
- Employees
- SAP N/A
- MRK N/A
- Industry
- SAP Computer Software: Prepackaged Software
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- SAP Technology
- MRK Health Care
- Exchange
- SAP Nasdaq
- MRK Nasdaq
- Market Cap
- SAP 272.8B
- MRK 260.8B
- IPO Year
- SAP 1998
- MRK N/A
- Fundamental
- Price
- SAP $262.74
- MRK $97.93
- Analyst Decision
- SAP Buy
- MRK Buy
- Analyst Count
- SAP 7
- MRK 15
- Target Price
- SAP $252.33
- MRK $125.36
- AVG Volume (30 Days)
- SAP 979.8K
- MRK 9.8M
- Earning Date
- SAP 01-28-2025
- MRK 02-04-2025
- Dividend Yield
- SAP 0.91%
- MRK 3.31%
- EPS Growth
- SAP N/A
- MRK 165.47
- EPS
- SAP 2.59
- MRK 4.78
- Revenue
- SAP $37,102,386,780.00
- MRK $63,174,000,000.00
- Revenue This Year
- SAP $9.80
- MRK $7.50
- Revenue Next Year
- SAP $11.29
- MRK $5.14
- P/E Ratio
- SAP $101.16
- MRK $20.49
- Revenue Growth
- SAP 8.00
- MRK 6.51
- 52 Week Low
- SAP $161.07
- MRK $94.48
- 52 Week High
- SAP $264.71
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- SAP 66.76
- MRK 42.35
- Support Level
- SAP $247.42
- MRK $98.05
- Resistance Level
- SAP $253.85
- MRK $100.90
- Average True Range (ATR)
- SAP 3.27
- MRK 1.75
- MACD
- SAP 1.22
- MRK 0.04
- Stochastic Oscillator
- SAP 91.78
- MRK 0.00
About SAP SAP SE ADS
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small- to medium-size enterprises.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.